Drug-coated balloon: Long-term outcome from a real world three-center experience
Autor: | Giovanni Benfari, Stefano Cordone, Bernhard Reimers, Matteo Ghione, Magdalena Cuman, Flavio Ribichini, Carlo Zivelonghi, Pietro Bellone, Mattia Lunardi, Andrea Pacchioni, Alfredo Fede, Marco Botta |
---|---|
Rok vydání: | 2017 |
Předmět: |
Male
medicine.medical_specialty small vessel disease Percutaneous Paclitaxel medicine.medical_treatment Population Myocardial Infarction drug-coated balloon Coronary Artery Disease Disease 030204 cardiovascular system & hematology Revascularization in-stent restenosis 03 medical and health sciences Postoperative Complications 0302 clinical medicine Restenosis Diabetes mellitus medicine Humans Radiology Nuclear Medicine and imaging Registries 030212 general & internal medicine Myocardial infarction Angioplasty Balloon Coronary education Aged Retrospective Studies education.field_of_study business.industry Middle Aged medicine.disease Surgery Treatment Outcome Italy Multivariate Analysis Female Cardiology and Cardiovascular Medicine business Mace |
Zdroj: | Journal of Interventional Cardiology. 30:318-324 |
ISSN: | 0896-4327 |
Popis: | Objectives In-stent restenosis (ISR) and diffuse small vessel disease still represent challenging subsets for percutaneous coronary interventions, also in the new-generation DES era. We aim at reporting on the long-term clinical outcome of drug-coated balloons (DCB) in all-comers population. Methods Consecutive patients treated with DCB between January 2011 and December 2014 were retrospectively studied in three centers of northern Italy. The measured end-points were cardiac death, myocardial infarction (MI), target lesion revascularization (TLR), and major adverse cardiac events (MACE) defined as combination of cardiac death, MI, and TLR. Results We included 143 patients. Of the 167 lesions treated, 41 (24.5%) were de novo lesions in small coronary vessels ( |
Databáze: | OpenAIRE |
Externí odkaz: | |
Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |